A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer

NCT02560974 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1035

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Hoffmann-La Roche